BIO SILKEBORG A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.3% 0.9% 0.7% 0.8% 0.9%  
Credit score (0-100)  81 89 94 92 86  
Credit rating  A A AA AA A  
Credit limit (kDKK)  112.3 507.9 796.1 748.3 365.6  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  7,059 3,378 4,545 5,323 4,927  
EBITDA  4,464 1,097 2,305 2,643 1,860  
EBIT  4,214 855 2,029 2,330 1,527  
Pre-tax profit (PTP)  4,574.3 597.4 2,414.3 2,263.4 1,551.1  
Net earnings  3,566.9 465.2 1,895.0 1,764.6 1,211.1  
Pre-tax profit without non-rec. items  4,574 597 2,414 2,263 1,551  

 
See the entire income statement

Balance sheet (DKKk) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  1,067 990 1,124 984 1,702  
Shareholders equity total  4,203 4,668 6,563 5,328 3,539  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,071 6,663 8,297 7,546 6,065  

Net Debt  -4,377 -4,876 -3,065 -5,178 -3,248  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  7,059 3,378 4,545 5,323 4,927  
Gross profit growth  9.4% -52.1% 34.6% 17.1% -7.4%  
Employees  8 8 5 5 5  
Employee growth %  0.0% 0.0% -37.5% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,071 6,663 8,297 7,546 6,065  
Balance sheet change%  3.9% -5.8% 24.5% -9.1% -19.6%  
Added value  4,464.0 1,097.0 2,305.4 2,606.5 1,860.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -218 -319 -143 -453 385  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  59.7% 25.3% 44.6% 43.8% 31.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  66.6% 13.4% 32.8% 30.6% 23.9%  
ROI %  111.5% 20.2% 43.0% 40.3% 35.7%  
ROE %  94.6% 10.5% 33.7% 29.7% 27.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  64.9% 77.8% 84.3% 74.7% 62.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -98.1% -444.5% -133.0% -196.0% -174.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  16.1% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.7 4.4 6.1 3.7 2.1  
Current Ratio  2.2 3.0 4.3 3.1 1.8  
Cash and cash equivalent  4,377.0 4,876.4 3,065.4 5,178.1 3,247.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,095.3 1,844.9 3,189.8 2,163.0 -310.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  558 137 461 521 372  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  558 137 461 529 372  
EBIT / employee  527 107 406 466 305  
Net earnings / employee  446 58 379 353 242